Skip to main content
. 2021 May 20;10(5):818. doi: 10.3390/antiox10050818

Figure 5.

Figure 5

Hidrox® administration reduced AD markers. Western blot analysis of hippocampus p-Tau (A) and APP (B) expression and β-amyloid levels (C). For the analyses, n = 5 animals in each group were employed. The results were analyzed by one-way ANOVA followed by a Bonferroni post-hoc test for multiple comparisons. Densitometric analysis of representative western blot analysis of APP expression (A): F (2,6) = 62.56, Densitometric analysis of representative western blot analysis of p-Tau expression (B): F (2,6) = 20.40, β-amyloid levels (C): F (2,12) = 16.43. A p-value of less than 0.05 was considered significant. # p < 0.05 vs. vehicle, ** p < 0.01 vs. sham, *** p < 0.001 vs. sham, ### p < 0.001 vs. vehicle.